The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,219,759 in first-year total cost, median $404,058.
Most frequent study sections
- Drug Discovery and Molecular Pharmacology B Study Section[DMPB]2
- Neurotoxicology and Alcohol Study Section[NAL]1
Most frequent institutions
- SAINT LOUIS UNIVERSITY1
- UNIVERSITY OF MINNESOTA1
- UNIVERSITY OF TENNESSEE HEALTH SCI CTR1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | A novel approach to restore functional TDP43 for the treatment of FTD and ALS1R21AG094188-01 | SACHS, JONATHAN N | UNIVERSITY OF MINNESOTA, MN | $404,058 | DMPB |
| 2025 | Repurposing FDA-Approved Drugs to Target Chronic Alcohol Tolerance1R21AA032393-01 | JEE, CHANG HOON | UNIVERSITY OF TENNESSEE HEALTH SCI CTR, TN | $399,076 | NAL |
| 2024 | Methods for treating aging-related cognitive decline and reducing risk of AD/ADRD by enhancing the endogenous expression of adropin1R21AG087308-01 | BUTLER, ANDREW ALISTAIRNGUYEN, ANDREW D. | SAINT LOUIS UNIVERSITY, MO | $416,625 | DMPB |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.